🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has taken down problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of joining one group, a vendor posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, health issues or past usage.

Product Information and Pricing

Within these communities, messages show black plastic parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.